PubMed

The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients.

Young DO, Cheng SC, Delmez JA, Coyne DW.

Perit Dial Int. 2009 Sep-Oct;29(5):562-7.PMID: 19776051 [PubMed - in process]Related articles

Seeking safe and efficacious anemia management.

Coyne DW, Brennan DC.

Semin Dial. 2009 Sep-Oct;22(5):590-1. Epub 2009 Sep 9. No abstract available. PMID: 19744148 [PubMed - in process]Related articles

Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients.

Gincherman Y, Moloney K, McKee C, Coyne DW.

Hemodial Int. 2009 Aug 28. [Epub ahead of print]PMID: 19732171 [PubMed - as supplied by publisher]Related articles

Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease.

Coyne DW.

Expert Opin Pharmacother. 2009 Oct;10(15):2563-8. Review.PMID: 19708851 [PubMed - indexed for MEDLINE]Related articles

Posttransplant anemia: the role of sirolimus.

Fishbane S, Cohen DJ, Coyne DW, Djamali A, Singh AK, Wish JB.

Kidney Int. 2009 Aug;76(4):376-82. Epub 2009 Jun 24.PMID: 19553912 [PubMed - in process]Related articles

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

Lambers Heerspink HJ, Agarwal R, Coyne DW, Parving HH, Ritz E, Remuzzi G, Audhya P, Amdahl MJ, Andress DL, de Zeeuw D.

Am J Nephrol. 2009;30(3):280-6. Epub 2009 Jun 15.PMID: 19521070 [PubMed - in process]Related articles

Results of an anemia management program to reduce high epoetin doses by targeted use of i.v. ferric gluconate.

Coyne DW, Sims A, Bingel B.

Nephrol Nurs J. 2008 Nov-Dec;35(6):583-7.PMID: 19260610 [PubMed - indexed for MEDLINE]Related articles

Managing anemia in for-profit dialysis chains: when ethics and business conflict.

Coyne DW.

Semin Dial. 2009 Jan-Feb;22(1):18-21. Review.PMID: 19250444 [PubMed - indexed for MEDLINE]Related articles

Iron deficiency anemia and iron losses after renal transplantation.

Zheng S, Coyne DW, Joist H, Schuessler R, Godboldo-Brooks A, Ercole P, Brennan DC.

Transpl Int. 2009 Apr;22(4):434-40. Epub 2008 Dec 9.PMID: 19076330 [PubMed - indexed for MEDLINE]Related articles

Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation.

Pizzi LT, Bunz TJ, Coyne DW, Goldfarb DS, Singh AK.

Kidney Int. 2008 Dec;74(12):1588-95. Epub 2008 Oct 1.PMID: 19034302 [PubMed - indexed for MEDLINE]Related articles

A comprehensive vision for intravenous iron therapy.

Coyne DW.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S14-20.PMID: 19010257 [PubMed - indexed for MEDLINE]Related articles

Introduction to "A road map for intravenous iron and anemia management: preparing for the future".

Coyne DW.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S1-4. No abstract available. PMID: 19010256 [PubMed - indexed for MEDLINE]Related articles

Variability of ferritin measurements in chronic kidney disease; implications for iron management.

Ford BA, Coyne DW, Eby CS, Scott MG.

Kidney Int. 2009 Jan;75(1):104-10. Epub 2008 Oct 8.PMID: 18843257 [PubMed - indexed for MEDLINE]Related articles

Comment on "Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels?".

Coyne DW, Trout JR, Kapoian T.

Nat Clin Pract Nephrol. 2008 Oct;4(10):E1; discussion E2. No abstract available. PMID: 18818660 [PubMed - indexed for MEDLINE]Related articles

Conflicts of interest and viewpoint bias in KDOQI and KDIGO workgroups.

Coyne DW.

Nephrol Dial Transplant. 2008 Dec;23(12):4071; author reply 4071-2. Epub 2008 Sep 3. No abstract available. PMID: 18768584 [PubMed - indexed for MEDLINE]Related articles

The TREAT study answers a question, not the question.

Coyne DW.

Am J Kidney Dis. 2008 Sep;52(3):626-7; author reply 627-8. No abstract available. PMID: 18725019 [PubMed - indexed for MEDLINE]Related articles

Vitamin D compounds in chronic kidney disease.

Coyne DW.

Ann Intern Med. 2008 Jun 17;148(12):969-70; author reply 970. No abstract available. PMID: 18559843 [PubMed - indexed for MEDLINE]Related articlesFree article

Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.

Coyne DW.

Nat Clin Pract Nephrol. 2008 Jul;4(7):364-5. Epub 2008 May 13. Review. No abstract available. PMID: 18477990 [PubMed - indexed for MEDLINE]Related articles

Relative mortality and epoetin alpha dose among hemodialysis patients.

Coyne DW.

Am J Kidney Dis. 2008 May;51(5):866-7; author reply 867. No abstract available. PMID: 18436101 [PubMed - indexed for MEDLINE]Related articles

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

Malluche HH, Monier-Faugere MC, Wang G, Frazã O JM, Charytan C, Coburn JW, Coyne DW, Kaplan MR, Baker N, McCary LC, Turner SA, Goodman WG.

Clin Nephrol. 2008 Apr;69(4):269-78.PMID: 18397701 [PubMed - indexed for MEDLINE]Related articles

Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?

Dahl NV, Henry DH, Coyne DW.

Semin Dial. 2008 May-Jun;21(3):210-1. Epub 2008 Apr 6.PMID: 18397204 [PubMed - indexed for MEDLINE]Related articles

A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.

Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1131-8. Epub 2008 Apr 2.PMID: 18385391 [PubMed - indexed for MEDLINE]Related articlesFree article

High-molecular weight iron dextran: a wolf in sheep's clothing?

Rodgers GM, Auerbach M, Cella D, Chertow GM, Coyne DW, Glaspy JA, Henry DH.

J Am Soc Nephrol. 2008 May;19(5):833-4. Epub 2008 Mar 27. No abstract available. PMID: 18369084 [PubMed - indexed for MEDLINE]Related articlesFree article

From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.

Coyne DW.

Semin Dial. 2008 May-Jun;21(3):212-6. Epub 2008 Mar 18. Review.PMID: 18363603 [PubMed - indexed for MEDLINE]Related articles

Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.

Andress DL, Coyne DW, Kalantar-Zadeh K, Molitch ME, Zangeneh F, Sprague SM.

Endocr Pract. 2008 Jan-Feb;14(1):18-27. Review.PMID: 18238737 [PubMed - indexed for MEDLINE]Related articles

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.

Kapoian T, O'Mara NB, Singh AK, Moran J, Rizkala AR, Geronemus R, Kopelman RC, Dahl NV, Coyne DW.

J Am Soc Nephrol. 2008 Feb;19(2):372-9. Epub 2008 Jan 23.PMID: 18216316 [PubMed - indexed for MEDLINE]Related articlesFree article

C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks.

Spinowitz B, Coyne DW, Lok CE, Fraticelli M, Azer M, Dalal S, Villa G, Rosansky S, Adamis H, Beyer U; RUBRA Study Investigators.

Am J Nephrol. 2008;28(2):280-9. Epub 2007 Nov 13.PMID: 18004064 [PubMed - indexed for MEDLINE]Related articles

Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies.

Wish JB, Coyne DW.

Mayo Clin Proc. 2007 Nov;82(11):1371-80. Review.PMID: 17976358 [PubMed - indexed for MEDLINE]Related articlesFree article

Practice recommendations based on low, very low, and missing evidence.

Coyne DW.

Clin J Am Soc Nephrol. 2007 Jan;2(1):11-2. Epub 2006 Dec 6. Review. No abstract available. PMID: 17699379 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of industry on renal guideline development.

Coyne DW.

Clin J Am Soc Nephrol. 2007 Jan;2(1):3-7; discussion 13-4. Epub 2006 Dec 6. Review. No abstract available. PMID: 17699377 [PubMed - indexed for MEDLINE]Related articlesFree article

ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.

Zheng S, Nath V, Coyne DW.

Am J Nephrol. 2007;27(5):522-9. Epub 2007 Aug 16.PMID: 17700014 [PubMed - indexed for MEDLINE]Related articles

Use of epoetin in chronic renal failure.

Coyne DW.

JAMA. 2007 Apr 18;297(15):1713-6. No abstract available. PMID: 17440149 [PubMed - indexed for MEDLINE]Related articles

Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation.

Singh AK, Coyne DW, Shapiro W, Rizkala AR; DRIVE Study Group.

Kidney Int. 2007 Jun;71(11):1163-71. Epub 2007 Mar 28.PMID: 17396118 [PubMed - indexed for MEDLINE]Related articles

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.

Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR; DRIVE Study Group.

J Am Soc Nephrol. 2007 Mar;18(3):975-84. Epub 2007 Jan 31.PMID: 17267740 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.

Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW.

Nephron Clin Pract. 2007;105(3):c132-8. Epub 2007 Jan 16.PMID: 17228173 [PubMed - indexed for MEDLINE]Related articles

Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.

Michael B, Fishbane S, Coyne DW, Agarwal R, Warnock DG.

Nat Clin Pract Nephrol. 2006 Feb;2(2):92-100. Review.PMID: 16932400 [PubMed - indexed for MEDLINE]Related articles

Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.

Joist HE, Ahya SN, Giles K, Norwood K, Slatopolsky E, Coyne DW.

Clin Nephrol. 2006 May;65(5):335-41.PMID: 16724654 [PubMed - indexed for MEDLINE]Related articles

Oral feeding acutely down-regulates serum PTH in hemodialysis patients.

Brown AJ, Koch MJ, Coyne DW.

Nephron Clin Pract. 2006;103(3):c106-13. Epub 2006 Mar 13.PMID: 16534234 [PubMed - indexed for MEDLINE]Related articles

Anemia in the kidney-transplant patient.

Joist H, Brennan DC, Coyne DW.

Adv Chronic Kidney Dis. 2006 Jan;13(1):4-10. Review.PMID: 16412965 [PubMed - indexed for MEDLINE]Related articles

Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients.

Staniforth ME, Cheng SC, Coyne DW.

Clin Nephrol. 2005 Jun;63(6):454-60.PMID: 15960147 [PubMed - indexed for MEDLINE]Related articles

Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism.

Brown AJ, Coyne DW.

Treat Endocrinol. 2002;1(5):313-27. Review.PMID: 15832485 [PubMed - indexed for MEDLINE]Related articles

The spectrum of infection-related morbidity in hospitalized haemodialysis patients.

Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Depner TA, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group.

Nephrol Dial Transplant. 2005 Jun;20(6):1180-6. Epub 2005 Mar 15.PMID: 15769823 [PubMed - indexed for MEDLINE]Related articlesFree article

Labile iron in parenteral iron formulations: a quantitative and comparative study.

Coyne DW.

Nephrol Dial Transplant. 2004 Oct;19(10):2674-5; author reply 2675-6. No abstract available. PMID: 15388831 [PubMed - indexed for MEDLINE]Related articlesFree article

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG.

N Engl J Med. 2004 Apr 8;350(15):1516-25.PMID: 15071126 [PubMed - indexed for MEDLINE]Related articlesFree article

Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safety.

Michael B, Coyne DW, Folkert VW, Dahl NV, Warnock DG; Ferrlecit Publication Committee.

Nephrol Dial Transplant. 2004 Jun;19(6):1576-80. Epub 2004 Mar 19.PMID: 15034152 [PubMed - indexed for MEDLINE]Related articlesFree article

Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.

Belani SS, Goldberg AC, Coyne DW.

Am J Kidney Dis. 2004 Feb;43(2):320-9.PMID: 14750098 [PubMed - indexed for MEDLINE]Related articles

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.

Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG.

Am J Med. 2003 Sep;115(4):291-7.PMID: 12967694 [PubMed - indexed for MEDLINE]Related articles

Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group.

J Am Soc Nephrol. 2003 Jul;14(7):1863-70.PMID: 12819247 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.

Folkert VW, Michael B, Agarwal R, Coyne DW, Dahl N, Myirski P, Warnock DG; Ferrlecit Publication Committee.

Am J Kidney Dis. 2003 Mar;41(3):651-7.PMID: 12612989 [PubMed - indexed for MEDLINE]Related articles

Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.

Coyne DW, Adkinson NF, Nissenson AR, Fishbane S, Agarwal R, Eschbach JW, Michael B, Folkert V, Batlle D, Trout JR, Dahl N, Myirski P, Strobos J, Warnock DG; Ferlecit Investigators.

Kidney Int. 2003 Jan;63(1):217-24.PMID: 12472786 [PubMed - indexed for MEDLINE]Related articles